Oncology Analytics Raises $28 Million Series C Financing Led by Baird Capital
National healthcare investor Baird Capital joins existing investors Oak HC/FT, McKesson Ventures and The Blue Venture Fund
FDA Oncology Drug Approvals
Q2 - 2020
Data Driven Utilization Management, Purpose Built for Oncology
Oncology Analytics® provides health plans, providers, and patients with a data-driven, utilization management solution that delivers real-world, evidence-based analytics focused exclusively for oncology
Oncology Analytics named to CB Insights’ Digital Health 150
The most promising 150 private digital health startups working to transform the healthcare industry with new models of primary care to emerging tech solutions for providers
Oncology Analytics provides the critical missing link for health plans by helping to manage the total cost of cancer care. By providing access to current, evidence-based, disease-specific analytics on all cancer types and treatment options, backed by board-certified oncology physicians and pharmacists, health plans are able to provide their members with the ability to achieve the best possible outcomes.
New Offering Designed to Help Health Plans Navigate the Anti-Cancer Drug Market to Improve Member Treatment Recommendations
National healthcare investor Baird Capital joins existing investors Oak HC/FT, McKesson Ventures and The Blue Venture Fund Atlanta, GA, May 26, 2020 — Oncology Analytics, a leading data analytics and technology-enabled services company dedicated to helping health...
Articles & Press
The following article is the fifth in a five-part series on The Top Five Ways for Health Plans to Manage Oncology Drug Costs While Improving Member Treatment Options.
JAVELIN Bladder 100 Phase III Results: Maintenance Avelumab + Best Supportive Case vs. BSC Alone After Platinum-Based First-Line Chemotherapy in Advanced Urothelial Carcinoma
The following article, written by Melissa Pozotrigo, Senior Clinical Oncology Pharmacist at Oncology Analytics, is the final of a four-part series on key trends and findings from the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program, held May 29-31, 2020.
WEBINAR: Health Plan Best Practices for Using Oncology Pharmacy Expertise to Navigate the Anti-cancer Drug Market
Date: Thursday, October 8th
11AM PDT | 2PM EDT